Class ITerminated in FDA datasetRecall initiated Jan 8, 2013

Woodstock All Natural Tamari Almonds, 7.5 OZ in a gusseted re-sealable poly bag.

Recalling firm: Woodstock Farms

Why it was recalled

Undeclared soy ingredient on mislabeled back panel. While the Tamari Almonds contain soy, the ingredient statement does not include soy. In addition, the nutrition facts and UPC#…

Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: May 18, 2015.

Check your package

Compare the exact product and package details with the label you have.

ProductWoodstock All Natural Tamari Almonds, 7.5 OZ in a gusseted re-sealable poly bag.
Package size7.5 OZ
UPC042563008383

FDA code information

Best By: 10/24/13 Lot: 12298 UPC# 0-42563-00838-3

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

Woodstock All Natural Tamari Almonds, 7.5 OZ in a gusseted re-sealable poly bag.

Extracted codes and context

TypeCode / valueContext
UPC042563008383Best By: 10/24/13 Lot: 12298 UPC# 0-42563-00838-3
best by10/24/13Best By: 10/24/13 Lot: 12298 UPC# 0-42563-00838-3
lot12298Best By: 10/24/13 Lot: 12298 UPC# 0-42563-00838-3

Original FDA recall reason

Undeclared soy ingredient on mislabeled back panel. While the Tamari Almonds contain soy, the ingredient statement does not include soy. In addition, the nutrition facts and UPC# are incorrect which corresponds to another almond product. People who have an allergy or severe sensitivity to soy run the risk of serious or life-threatening allergic reaction if they consume this product.

Recall details

Recall number
F-0886-2013
Event ID
64046
FDA status
Terminated
Initiated
Jan 8, 2013
Reported
Jan 23, 2013
Classified
Jan 16, 2013
Terminated
May 18, 2015
Quantity
67 cases, each containing 8 packages per shipping case
Location
Edison, NJ, United States
Initiation type
Voluntary: Firm initiated
Notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Where it was distributed

Alabama, Connecticut, Florida, Georgia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Vermont, Virginia, Wisconsin, and District of Columbia

FDA source record · F-0886-2013

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.